Working… Menu

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (MEND II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02189499
Recruitment Status : Unknown
Verified June 2016 by Amaranth Medical Inc..
Recruitment status was:  Active, not recruiting
First Posted : July 14, 2014
Last Update Posted : June 8, 2016
Information provided by (Responsible Party):
Amaranth Medical Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2016
Estimated Study Completion Date : November 2020
Granada JF. The Amaranth PLLA based bioresorbable scaffold (ABRS): Experimental and early human results. TCT presentation 2013.
Granada JF. BRS with clinical data III, Amaranth: Differentiating features and clinical update. TCT presentation 2014.